Latest News and Events
Filter by
Selections
October 3, 2023
Arrowhead Pharmaceuticals to Participate in Upcoming October 2023 Conferences
Read MoreSeptember 27, 2023
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Read MoreSeptember 1, 2023
Arrowhead Pharmaceuticals to Participate in Upcoming September 2023 Conferences
Read MoreJuly 17, 2023
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate a Phase 1/2 Study of ARO-DUX4 for Facioscapulohumeral Muscular Dystrophy
Read MoreJuly 6, 2023
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Read MoreJune 27, 2023